Structure

Physi-Chem Properties

Molecular Weight:  334.21
Volume:  350.138
LogP:  1.502
LogD:  0.78
LogS:  -3.41
# Rotatable Bonds:  0
TPSA:  77.76
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.593
Synthetic Accessibility Score:  5.825
Fsp3:  0.85
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.851
MDCK Permeability:  1.942229391715955e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.105
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.073
30% Bioavailability (F30%):  0.147

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.534
Plasma Protein Binding (PPB):  44.41900634765625%
Volume Distribution (VD):  0.911
Pgp-substrate:  51.32514953613281%

ADMET: Metabolism

CYP1A2-inhibitor:  0.026
CYP1A2-substrate:  0.104
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.46
CYP2C9-inhibitor:  0.041
CYP2C9-substrate:  0.386
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.349
CYP3A4-inhibitor:  0.019
CYP3A4-substrate:  0.184

ADMET: Excretion

Clearance (CL):  3.886
Half-life (T1/2):  0.354

ADMET: Toxicity

hERG Blockers:  0.075
Human Hepatotoxicity (H-HT):  0.123
Drug-inuced Liver Injury (DILI):  0.042
AMES Toxicity:  0.161
Rat Oral Acute Toxicity:  0.969
Maximum Recommended Daily Dose:  0.983
Skin Sensitization:  0.598
Carcinogencity:  0.033
Eye Corrosion:  0.014
Eye Irritation:  0.166
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470378

Natural Product ID:  NPC470378
Common Name*:   Pseurata A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  BAXVJERFBZODKZ-UKZCGEBOSA-N
Standard InCHI:  InChI=1S/C20H30O4/c1-10-11-5-6-12-19(4)8-7-14(21)18(2,3)13(19)9-15(22)20(12,16(10)23)17(11)24/h11-15,17,21-22,24H,1,5-9H2,2-4H3/t11-,12?,13+,14+,15+,17+,19-,20-/m0/s1
SMILES:  C=C1[C@@H]2CCC3[C@](C1=O)([C@@H]2O)[C@H](O)C[C@H]1[C@@]3(C)CC[C@H](C1(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2021470
PubChem CID:   70691855
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24459 Isodon pharicus Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19425589]
NPO24459 Isodon pharicus Species Lamiaceae Eukaryota Aerial Parts n.a. n.a. PMID[29286250]
NPO24459 Isodon pharicus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24459 Isodon pharicus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24459 Isodon pharicus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2678 Cell Line NB-4 Homo sapiens IC50 = 7690.0 nM PMID[549738]
NPT81 Cell Line A549 Homo sapiens IC50 = 2920.0 nM PMID[549738]
NPT519 Cell Line SH-SY5Y Homo sapiens IC50 > 10000.0 nM PMID[549738]
NPT306 Cell Line PC-3 Homo sapiens IC50 > 10000.0 nM PMID[549738]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 9050.0 nM PMID[549738]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470378 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC261994
1.0 High Similarity NPC149761
0.9882 High Similarity NPC299185
0.9767 High Similarity NPC144739
0.9767 High Similarity NPC181594
0.9655 High Similarity NPC104371
0.9655 High Similarity NPC215271
0.9655 High Similarity NPC292374
0.9655 High Similarity NPC129004
0.9655 High Similarity NPC91772
0.9655 High Similarity NPC64006
0.9655 High Similarity NPC29247
0.9655 High Similarity NPC101233
0.9655 High Similarity NPC111524
0.9655 High Similarity NPC289539
0.9655 High Similarity NPC153775
0.9655 High Similarity NPC261333
0.9651 High Similarity NPC476168
0.9643 High Similarity NPC165895
0.9545 High Similarity NPC138245
0.9545 High Similarity NPC231060
0.9545 High Similarity NPC84018
0.9535 High Similarity NPC80401
0.9535 High Similarity NPC180849
0.9438 High Similarity NPC135548
0.9438 High Similarity NPC140242
0.9438 High Similarity NPC264979
0.9432 High Similarity NPC191094
0.9432 High Similarity NPC302008
0.9412 High Similarity NPC259009
0.9405 High Similarity NPC190704
0.9405 High Similarity NPC471034
0.9405 High Similarity NPC102292
0.9318 High Similarity NPC59170
0.9318 High Similarity NPC59350
0.9231 High Similarity NPC16911
0.9231 High Similarity NPC78427
0.9186 High Similarity NPC153604
0.9186 High Similarity NPC174619
0.9167 High Similarity NPC471036
0.9167 High Similarity NPC291320
0.913 High Similarity NPC287676
0.913 High Similarity NPC156324
0.913 High Similarity NPC127408
0.913 High Similarity NPC291785
0.913 High Similarity NPC55503
0.9111 High Similarity NPC29112
0.9111 High Similarity NPC210214
0.9048 High Similarity NPC110780
0.9032 High Similarity NPC471790
0.9032 High Similarity NPC289148
0.9032 High Similarity NPC163963
0.9032 High Similarity NPC52899
0.9011 High Similarity NPC13949
0.8989 High Similarity NPC211403
0.8989 High Similarity NPC278106
0.8989 High Similarity NPC198242
0.8936 High Similarity NPC309388
0.8936 High Similarity NPC214946
0.8936 High Similarity NPC246736
0.8936 High Similarity NPC88203
0.8936 High Similarity NPC286519
0.8936 High Similarity NPC475803
0.8936 High Similarity NPC148628
0.8936 High Similarity NPC76866
0.8936 High Similarity NPC304832
0.8889 High Similarity NPC82138
0.8842 High Similarity NPC87927
0.8842 High Similarity NPC216114
0.8837 High Similarity NPC146683
0.8791 High Similarity NPC470386
0.8791 High Similarity NPC470385
0.8791 High Similarity NPC280804
0.8791 High Similarity NPC47853
0.875 High Similarity NPC98603
0.875 High Similarity NPC84928
0.875 High Similarity NPC13149
0.8737 High Similarity NPC272472
0.8721 High Similarity NPC118800
0.8696 High Similarity NPC41070
0.8696 High Similarity NPC470232
0.8667 High Similarity NPC100313
0.8667 High Similarity NPC46758
0.866 High Similarity NPC12823
0.866 High Similarity NPC4115
0.8632 High Similarity NPC60947
0.8632 High Similarity NPC46848
0.8617 High Similarity NPC471038
0.8602 High Similarity NPC329910
0.8602 High Similarity NPC470387
0.8587 High Similarity NPC475118
0.8571 High Similarity NPC67745
0.8571 High Similarity NPC471461
0.8571 High Similarity NPC250753
0.8557 High Similarity NPC474558
0.8557 High Similarity NPC202793
0.8542 High Similarity NPC275990
0.8539 High Similarity NPC472497
0.8526 High Similarity NPC470388
0.8523 High Similarity NPC76518
0.8511 High Similarity NPC170978
0.8511 High Similarity NPC10864
0.8495 Intermediate Similarity NPC470229
0.8495 Intermediate Similarity NPC472485
0.8495 Intermediate Similarity NPC98639
0.8485 Intermediate Similarity NPC469729
0.8485 Intermediate Similarity NPC218123
0.8485 Intermediate Similarity NPC112895
0.8485 Intermediate Similarity NPC231278
0.8485 Intermediate Similarity NPC55973
0.8485 Intermediate Similarity NPC469733
0.8478 Intermediate Similarity NPC294263
0.8454 Intermediate Similarity NPC470310
0.8454 Intermediate Similarity NPC139347
0.8452 Intermediate Similarity NPC106078
0.8444 Intermediate Similarity NPC472739
0.8438 Intermediate Similarity NPC14634
0.8438 Intermediate Similarity NPC71706
0.8421 Intermediate Similarity NPC28864
0.8421 Intermediate Similarity NPC89099
0.8421 Intermediate Similarity NPC38471
0.8421 Intermediate Similarity NPC20479
0.8421 Intermediate Similarity NPC98837
0.8421 Intermediate Similarity NPC162459
0.8421 Intermediate Similarity NPC38296
0.8421 Intermediate Similarity NPC474793
0.8409 Intermediate Similarity NPC475745
0.8409 Intermediate Similarity NPC474482
0.8404 Intermediate Similarity NPC200054
0.8404 Intermediate Similarity NPC234564
0.8404 Intermediate Similarity NPC29410
0.8391 Intermediate Similarity NPC46881
0.8384 Intermediate Similarity NPC469746
0.8352 Intermediate Similarity NPC471043
0.8352 Intermediate Similarity NPC213832
0.8352 Intermediate Similarity NPC57954
0.8333 Intermediate Similarity NPC472495
0.8333 Intermediate Similarity NPC293866
0.8333 Intermediate Similarity NPC57469
0.8317 Intermediate Similarity NPC471093
0.8317 Intermediate Similarity NPC473324
0.83 Intermediate Similarity NPC189663
0.83 Intermediate Similarity NPC273155
0.83 Intermediate Similarity NPC89860
0.83 Intermediate Similarity NPC211224
0.8298 Intermediate Similarity NPC142352
0.8298 Intermediate Similarity NPC288906
0.8298 Intermediate Similarity NPC263135
0.8295 Intermediate Similarity NPC475726
0.8295 Intermediate Similarity NPC472743
0.8283 Intermediate Similarity NPC37600
0.8283 Intermediate Similarity NPC138908
0.8283 Intermediate Similarity NPC200957
0.828 Intermediate Similarity NPC244356
0.828 Intermediate Similarity NPC472496
0.828 Intermediate Similarity NPC224060
0.8265 Intermediate Similarity NPC122811
0.8265 Intermediate Similarity NPC159442
0.8265 Intermediate Similarity NPC96217
0.8265 Intermediate Similarity NPC209298
0.8265 Intermediate Similarity NPC277074
0.8247 Intermediate Similarity NPC236585
0.8247 Intermediate Similarity NPC148279
0.8242 Intermediate Similarity NPC471724
0.8242 Intermediate Similarity NPC146937
0.8242 Intermediate Similarity NPC193360
0.8242 Intermediate Similarity NPC474719
0.8242 Intermediate Similarity NPC474677
0.8242 Intermediate Similarity NPC471900
0.8235 Intermediate Similarity NPC122339
0.8235 Intermediate Similarity NPC29505
0.8235 Intermediate Similarity NPC329953
0.8229 Intermediate Similarity NPC109059
0.8229 Intermediate Similarity NPC288
0.8222 Intermediate Similarity NPC472738
0.8222 Intermediate Similarity NPC269396
0.8222 Intermediate Similarity NPC98236
0.8218 Intermediate Similarity NPC469744
0.8218 Intermediate Similarity NPC118721
0.8218 Intermediate Similarity NPC102741
0.8218 Intermediate Similarity NPC252679
0.8211 Intermediate Similarity NPC104568
0.82 Intermediate Similarity NPC176949
0.82 Intermediate Similarity NPC201908
0.82 Intermediate Similarity NPC166993
0.8191 Intermediate Similarity NPC196485
0.8191 Intermediate Similarity NPC209662
0.8191 Intermediate Similarity NPC111015
0.8191 Intermediate Similarity NPC245972
0.8182 Intermediate Similarity NPC96268
0.8172 Intermediate Similarity NPC470230
0.8172 Intermediate Similarity NPC131872
0.8155 Intermediate Similarity NPC473303
0.8155 Intermediate Similarity NPC145625
0.8155 Intermediate Similarity NPC471245
0.8152 Intermediate Similarity NPC1015
0.8152 Intermediate Similarity NPC31985
0.8152 Intermediate Similarity NPC119416
0.8144 Intermediate Similarity NPC108371
0.8144 Intermediate Similarity NPC267921

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470378 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.809 Intermediate Similarity NPD4788 Approved
0.8022 Intermediate Similarity NPD3618 Phase 1
0.7912 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD4786 Approved
0.7789 Intermediate Similarity NPD6079 Approved
0.7788 Intermediate Similarity NPD4634 Approved
0.7778 Intermediate Similarity NPD3667 Approved
0.7778 Intermediate Similarity NPD5286 Approved
0.7778 Intermediate Similarity NPD5285 Approved
0.7778 Intermediate Similarity NPD4696 Approved
0.7766 Intermediate Similarity NPD5328 Approved
0.7755 Intermediate Similarity NPD4755 Approved
0.7708 Intermediate Similarity NPD4202 Approved
0.7653 Intermediate Similarity NPD5221 Approved
0.7653 Intermediate Similarity NPD5222 Approved
0.7653 Intermediate Similarity NPD4697 Phase 3
0.7653 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD5211 Phase 2
0.7624 Intermediate Similarity NPD5224 Approved
0.7624 Intermediate Similarity NPD5226 Approved
0.7624 Intermediate Similarity NPD5225 Approved
0.7624 Intermediate Similarity NPD4633 Approved
0.7609 Intermediate Similarity NPD3666 Approved
0.7609 Intermediate Similarity NPD3665 Phase 1
0.7609 Intermediate Similarity NPD3133 Approved
0.7604 Intermediate Similarity NPD8034 Phase 2
0.7604 Intermediate Similarity NPD8035 Phase 2
0.76 Intermediate Similarity NPD4700 Approved
0.7586 Intermediate Similarity NPD3703 Phase 2
0.7579 Intermediate Similarity NPD4753 Phase 2
0.7576 Intermediate Similarity NPD5173 Approved
0.7551 Intermediate Similarity NPD5210 Approved
0.7551 Intermediate Similarity NPD4629 Approved
0.7549 Intermediate Similarity NPD5174 Approved
0.7549 Intermediate Similarity NPD5175 Approved
0.7528 Intermediate Similarity NPD6697 Approved
0.7528 Intermediate Similarity NPD6118 Approved
0.7528 Intermediate Similarity NPD6114 Approved
0.7528 Intermediate Similarity NPD6115 Approved
0.7525 Intermediate Similarity NPD5223 Approved
0.7476 Intermediate Similarity NPD5141 Approved
0.7442 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD7515 Phase 2
0.7412 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD6399 Phase 3
0.7333 Intermediate Similarity NPD5697 Approved
0.7303 Intermediate Similarity NPD6117 Approved
0.7264 Intermediate Similarity NPD4729 Approved
0.7264 Intermediate Similarity NPD5128 Approved
0.7264 Intermediate Similarity NPD6881 Approved
0.7264 Intermediate Similarity NPD6899 Approved
0.7264 Intermediate Similarity NPD4730 Approved
0.7238 Intermediate Similarity NPD7128 Approved
0.7238 Intermediate Similarity NPD6675 Approved
0.7238 Intermediate Similarity NPD4767 Approved
0.7238 Intermediate Similarity NPD6402 Approved
0.7238 Intermediate Similarity NPD5739 Approved
0.7238 Intermediate Similarity NPD4768 Approved
0.7234 Intermediate Similarity NPD3668 Phase 3
0.7222 Intermediate Similarity NPD6116 Phase 1
0.7222 Intermediate Similarity NPD6650 Approved
0.7222 Intermediate Similarity NPD6649 Approved
0.7212 Intermediate Similarity NPD4754 Approved
0.7209 Intermediate Similarity NPD3698 Phase 2
0.7207 Intermediate Similarity NPD7115 Discovery
0.7204 Intermediate Similarity NPD4221 Approved
0.7204 Intermediate Similarity NPD4223 Phase 3
0.7196 Intermediate Similarity NPD6372 Approved
0.7196 Intermediate Similarity NPD6014 Approved
0.7196 Intermediate Similarity NPD6012 Approved
0.7196 Intermediate Similarity NPD6013 Approved
0.7196 Intermediate Similarity NPD6373 Approved
0.7174 Intermediate Similarity NPD7525 Registered
0.717 Intermediate Similarity NPD5701 Approved
0.7168 Intermediate Similarity NPD6319 Approved
0.7168 Intermediate Similarity NPD6054 Approved
0.7157 Intermediate Similarity NPD7638 Approved
0.713 Intermediate Similarity NPD5249 Phase 3
0.713 Intermediate Similarity NPD5251 Approved
0.713 Intermediate Similarity NPD6883 Approved
0.713 Intermediate Similarity NPD7102 Approved
0.713 Intermediate Similarity NPD5250 Approved
0.713 Intermediate Similarity NPD7290 Approved
0.713 Intermediate Similarity NPD5247 Approved
0.713 Intermediate Similarity NPD5248 Approved
0.7126 Intermediate Similarity NPD4244 Approved
0.7126 Intermediate Similarity NPD4245 Approved
0.7105 Intermediate Similarity NPD6016 Approved
0.7105 Intermediate Similarity NPD6015 Approved
0.7103 Intermediate Similarity NPD6011 Approved
0.7103 Intermediate Similarity NPD7320 Approved
0.71 Intermediate Similarity NPD7748 Approved
0.7091 Intermediate Similarity NPD4632 Approved
0.7087 Intermediate Similarity NPD7639 Approved
0.7087 Intermediate Similarity NPD7640 Approved
0.7083 Intermediate Similarity NPD5279 Phase 3
0.7079 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD6008 Approved
0.7064 Intermediate Similarity NPD5217 Approved
0.7064 Intermediate Similarity NPD8130 Phase 1
0.7064 Intermediate Similarity NPD6847 Approved
0.7064 Intermediate Similarity NPD6617 Approved
0.7064 Intermediate Similarity NPD6869 Approved
0.7064 Intermediate Similarity NPD5215 Approved
0.7064 Intermediate Similarity NPD5216 Approved
0.7059 Intermediate Similarity NPD6084 Phase 2
0.7059 Intermediate Similarity NPD6083 Phase 2
0.7059 Intermediate Similarity NPD7902 Approved
0.7053 Intermediate Similarity NPD4197 Approved
0.7043 Intermediate Similarity NPD5988 Approved
0.7043 Intermediate Similarity NPD6370 Approved
0.7018 Intermediate Similarity NPD6059 Approved
0.7 Intermediate Similarity NPD6882 Approved
0.7 Intermediate Similarity NPD8297 Approved
0.699 Remote Similarity NPD5696 Approved
0.699 Remote Similarity NPD4225 Approved
0.6989 Remote Similarity NPD4695 Discontinued
0.6979 Remote Similarity NPD5329 Approved
0.6972 Remote Similarity NPD5169 Approved
0.6972 Remote Similarity NPD5135 Approved
0.6972 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6944 Remote Similarity NPD5168 Approved
0.6941 Remote Similarity NPD3171 Clinical (unspecified phase)
0.6932 Remote Similarity NPD4789 Approved
0.6923 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7492 Approved
0.6909 Remote Similarity NPD5127 Approved
0.6907 Remote Similarity NPD4689 Approved
0.6907 Remote Similarity NPD4693 Phase 3
0.6907 Remote Similarity NPD4138 Approved
0.6907 Remote Similarity NPD4690 Approved
0.6907 Remote Similarity NPD5205 Approved
0.6907 Remote Similarity NPD4688 Approved
0.6907 Remote Similarity NPD5690 Phase 2
0.6903 Remote Similarity NPD6009 Approved
0.6897 Remote Similarity NPD5360 Phase 3
0.6897 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6891 Remote Similarity NPD7736 Approved
0.6864 Remote Similarity NPD6616 Approved
0.6863 Remote Similarity NPD5695 Phase 3
0.6852 Remote Similarity NPD6412 Phase 2
0.6814 Remote Similarity NPD6274 Approved
0.6813 Remote Similarity NPD6942 Approved
0.6813 Remote Similarity NPD7339 Approved
0.6807 Remote Similarity NPD7078 Approved
0.6789 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6783 Remote Similarity NPD4522 Approved
0.6774 Remote Similarity NPD3617 Approved
0.6774 Remote Similarity NPD3671 Phase 1
0.6768 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6765 Remote Similarity NPD7900 Approved
0.6765 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6735 Remote Similarity NPD4694 Approved
0.6735 Remote Similarity NPD6409 Approved
0.6735 Remote Similarity NPD5330 Approved
0.6735 Remote Similarity NPD7521 Approved
0.6735 Remote Similarity NPD6684 Approved
0.6735 Remote Similarity NPD7334 Approved
0.6735 Remote Similarity NPD5280 Approved
0.6735 Remote Similarity NPD7146 Approved
0.6733 Remote Similarity NPD5281 Approved
0.6733 Remote Similarity NPD5284 Approved
0.6726 Remote Similarity NPD5167 Approved
0.6702 Remote Similarity NPD7645 Phase 2
0.6702 Remote Similarity NPD4195 Approved
0.6699 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8293 Discontinued
0.6667 Remote Similarity NPD5983 Phase 2
0.6667 Remote Similarity NPD4758 Discontinued
0.6667 Remote Similarity NPD4224 Phase 2
0.6638 Remote Similarity NPD7101 Approved
0.6638 Remote Similarity NPD7100 Approved
0.6637 Remote Similarity NPD8133 Approved
0.6636 Remote Similarity NPD7632 Discontinued
0.6629 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6609 Remote Similarity NPD6317 Approved
0.6602 Remote Similarity NPD5282 Discontinued
0.66 Remote Similarity NPD6903 Approved
0.66 Remote Similarity NPD5737 Approved
0.66 Remote Similarity NPD6672 Approved
0.6569 Remote Similarity NPD7637 Suspended
0.6569 Remote Similarity NPD6411 Approved
0.6562 Remote Similarity NPD4692 Approved
0.6562 Remote Similarity NPD4139 Approved
0.6557 Remote Similarity NPD7319 Approved
0.6555 Remote Similarity NPD8328 Phase 3
0.6555 Remote Similarity NPD7604 Phase 2
0.6552 Remote Similarity NPD6335 Approved
0.6552 Remote Similarity NPD6313 Approved
0.6552 Remote Similarity NPD6314 Approved
0.6526 Remote Similarity NPD6929 Approved
0.6525 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6868 Approved
0.6484 Remote Similarity NPD6081 Approved
0.6481 Remote Similarity NPD5091 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data